Source

Literatura:
Hong N. Y., Cui Z. G., Kang H. K., Lee D. H., Lee Y. K., Park D. B., p-Synephrine stimulates glucose consumption via AMPK in L6 skeletal muscle cells,
Biochem Biophys Res Commun., 2012; 418(4):720,
Schmitt G. C., Arbo H.D., Lorensi A. L., Maciel E. S., Krahn C. L., Mariotti K. C., Dallegrave E., Leal M. B., Limberger R. P., Toxicological effects of a mixture used in weight loss products: p-synephrine associated with ephedrine, salicin, and caffeine, Int J Toxicol, 2012; 31(2):184,
https://www.wada-ama.org/en/media/news/2016-09/wada-publishes-2017-prohibited-list
,
Yang S., Comprehensive Utilization of Citrus By-Products, Elsevier, 2017,
http://www.bfr.bund.de/de/a-z_index/synephrin-132686.html
,
Stohs S. J., Preuss H. G., Keith S. C., Keith P. L., Miller H., Kaats G. R., Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes. Int J Med Sci. 2011 Apr 28;8(4):295-301,
Kania M i in., Glukomannan i inne substancje pochodzenia roślinnego stosowane w leczeniu otyłości oraz chorób towarzyszących, Postępy fitoterapii, t. 14, nr 2 (2013), s. 132